Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
Beam Therapeutics sues Chinese biotech over alleged theft of trade secrets.
5 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 5 separate news trends connected to Biotech Industry, spanning August 25, 2026 through September 30, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 28 article observations and 27 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Beam Therapeutics sues Chinese biotech over alleged theft of trade secrets.
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Eli Lilly's acquisition of Merida Biosciences for up to $2.875 billion is making waves in the biotech industry.
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.
A $245 million patent dispute verdict has investors watching Guardant Health's next moves.